Political UncertaintyPolitical uncertainties tied to major shareholders could lead to delays, revisions to deal terms, or derailment of the transaction.
Regulatory Approval RiskTransaction requires shareholder approval, an Israeli authority review of the golden share, and multiple antitrust clearances, creating significant execution risk to completion.
Residual Execution RiskStructural fixes in the deal do not remove execution risk, leaving the transaction vulnerable to regulatory objections or unforeseen legal challenges.